- Home
- CRNX vs GHC Comparison
CRNX vs GHC Comparison
Compare CRNX & GHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNX | GHC |
|---|---|---|
| Founded | 2008 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.4B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CRNX | GHC |
|---|---|---|
| Price | $38.57 | $1,059.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $74.78 | N/A |
| AVG Volume (30 Days) | ★ 935.7K | 14.9K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.71% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 66.47 |
| Revenue | $1,039,000.00 | ★ $2,932,099,000.00 |
| Revenue This Year | $730.30 | $10.54 |
| Revenue Next Year | $179.48 | $4.02 |
| P/E Ratio | ★ N/A | $16.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $24.10 | $875.60 |
| 52 Week High | $57.99 | $1,224.76 |
Technical Indicators
Market Signals| Indicator | CRNX | GHC |
|---|---|---|
| Relative Strength Index (RSI) | 26.18 | 43.02 |
| Support Level | $33.23 | $1,060.95 |
| Resistance Level | $45.32 | $1,115.27 |
| Average True Range (ATR) | 1.87 | 32.80 |
| MACD | -0.40 | 0.20 |
| Stochastic Oscillator | 6.93 | 55.54 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About GHC Graham Holdings Company
Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.